FRES: fresh2.co Projected Price to Earnings

FRES (fresh2.co) - company brandmark

The forward P/E for the next year of Fresh2 Group Limited (FRES) is reacting to price volatility and logistical risks within the fresh produce segment, with the 0.00 mark reflecting the latest data. Scalability is driven by a warehouse-less B2B model, while the digitalization of supply chains via AI solutions expands the distributor pool. This chart's price action allows for an assessment of the market consensus regarding capitalization payback through expected earnings.

Market Cap to Projected Earnings: Fresh2 Group Limited (FRES) for 02/21/2024 - 01/04/2025

Analytical breakdowns and data insights for company Fresh2 (FRES)

- stock value and consensus price forecast:
Fundamental company valuation:FRES Fresh2 Group
Signature product of Fresh2

By developing a digital B2B platform to optimize food logistics, Fresh2 Group Limited is laying the foundation for scalability through the automation of small business procurement. The company's forward P/E valuation correlates current market value with expected earnings, allowing investors to determine whether the premium for technological growth is justified by actual expansion rates and the cost of capital.

Direct competitors

Future Price to Earnings Agilent (A)|Future Price to Earnings DGX (Quest Diagnostics Inc.)|Illumina Corp - Projected Price to Earnings|Exact Sciences Inc. (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings bio-rad.com BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings QuidelOrtho Corp|OPKO Health Corp. (OPK) - Market Cap to Projected Earnings|Forward P/E Multiple CDNA|MRVI: Price to Expected Earnings Ratio|Future Price to Earnings Fulgent Genetics FLGT|Future Price to Earnings Multiple LAB|Cytek Bio - Forward P/E Multiple|Projected Price to Earnings Ratio OraSure Corp|exagen.com (XGN) - Future Price to Earnings|MDXH - Market Cap to Projected Earnings|LUCD (Lucid Diagnostics) - Forward P/E Multiple|PRE: Future Price to Earnings Multiple|Future Price to Earnings Insight Molecular Diagnostics (IMDX)|Projected Price to Earnings trinitybiotech.com TRIB|Future Price to Earnings Multiple ProPhase Labs, Inc.|Forward P/E Multiple ainos.com AIMD|Forward Price to Earnings Multiple CODX|HSCS: Future Price to Earnings|Future Price to Earnings Multiple Biomerica, Inc BMRA|CDIO (Cardio Diagnostics Holdings) - Future Price to Earnings|Projected Price to Earnings Ratio ONCO (Onconetix, Inc.)|Projected Price to Earnings viraxbiolabs.com (VRAX)|Forward P/E Multiple BJDX|Future Price to Earnings AWH (Aspira Women's Health, Inc.)|Accelerate Diagnostics, Inc (AXDX) - Price to Expected Earnings Ratio|CNTG - Projected Price to Earnings|Future Price to Earnings Multiple Enzo (ENZ)|GENE: Future Price to Earnings|23andMe (ME) - Future Price to Earnings|Psychemedics Corp. (PMD) - Forward P/E Multiple